310 related articles for article (PubMed ID: 22426402)
1. Regional deficiencies in chaperone-mediated autophagy underlie α-synuclein aggregation and neurodegeneration.
Malkus KA; Ischiropoulos H
Neurobiol Dis; 2012 Jun; 46(3):732-44. PubMed ID: 22426402
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
3. Lysosome membrane lipid microdomains: novel regulators of chaperone-mediated autophagy.
Kaushik S; Massey AC; Cuervo AM
EMBO J; 2006 Sep; 25(17):3921-33. PubMed ID: 16917501
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.
Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM
Mov Disord; 2015 Oct; 30(12):1639-47. PubMed ID: 25594542
[TBL] [Abstract][Full Text] [Related]
5. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.
Giasson BI; Duda JE; Quinn SM; Zhang B; Trojanowski JQ; Lee VM
Neuron; 2002 May; 34(4):521-33. PubMed ID: 12062037
[TBL] [Abstract][Full Text] [Related]
6. Structure of transmembrane domain of lysosome-associated membrane protein type 2a (LAMP-2A) reveals key features for substrate specificity in chaperone-mediated autophagy.
Rout AK; Strub MP; Piszczek G; Tjandra N
J Biol Chem; 2014 Dec; 289(51):35111-23. PubMed ID: 25342746
[TBL] [Abstract][Full Text] [Related]
7. Chaperone-mediated autophagy.
Dice JF
Autophagy; 2007; 3(4):295-9. PubMed ID: 17404494
[TBL] [Abstract][Full Text] [Related]
8. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain.
Issa AR; Sun J; Petitgas C; Mesquita A; Dulac A; Robin M; Mollereau B; Jenny A; Chérif-Zahar B; Birman S
Autophagy; 2018; 14(11):1898-1910. PubMed ID: 29989488
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal degradation of alpha-synuclein in vivo.
Mak SK; McCormack AL; Manning-Bog AB; Cuervo AM; Di Monte DA
J Biol Chem; 2010 Apr; 285(18):13621-9. PubMed ID: 20200163
[TBL] [Abstract][Full Text] [Related]
10. Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age.
Kiffin R; Kaushik S; Zeng M; Bandyopadhyay U; Zhang C; Massey AC; Martinez-Vicente M; Cuervo AM
J Cell Sci; 2007 Mar; 120(Pt 5):782-91. PubMed ID: 17284523
[TBL] [Abstract][Full Text] [Related]
11. The role of chaperone-mediated autophagy in neurotoxicity induced by alpha-synuclein after methamphetamine exposure.
Sun L; Lian Y; Ding J; Meng Y; Li C; Chen L; Qiu P
Brain Behav; 2019 Aug; 9(8):e01352. PubMed ID: 31286692
[TBL] [Abstract][Full Text] [Related]
12. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
13. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane.
Bandyopadhyay U; Kaushik S; Varticovski L; Cuervo AM
Mol Cell Biol; 2008 Sep; 28(18):5747-63. PubMed ID: 18644871
[TBL] [Abstract][Full Text] [Related]
14. Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies.
Wei J; Fujita M; Nakai M; Waragai M; Sekigawa A; Sugama S; Takenouchi T; Masliah E; Hashimoto M
Am J Pathol; 2009 May; 174(5):1891-909. PubMed ID: 19349362
[TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy.
Wu JZ; Ardah M; Haikal C; Svanbergsson A; Diepenbroek M; Vaikath NN; Li W; Wang ZY; Outeiro TF; El-Agnaf OM; Li JY
Transl Neurodegener; 2019; 8():18. PubMed ID: 31223479
[TBL] [Abstract][Full Text] [Related]
16. Entering the lysosome through a transient gate by chaperone-mediated autophagy.
Bandyopadhyay U; Cuervo AM
Autophagy; 2008 Nov; 4(8):1101-3. PubMed ID: 18927485
[TBL] [Abstract][Full Text] [Related]
17. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
Alvarez-Erviti L; Seow Y; Schapira AH; Rodriguez-Oroz MC; Obeso JA; Cooper JM
Cell Death Dis; 2013 Mar; 4(3):e545. PubMed ID: 23492776
[TBL] [Abstract][Full Text] [Related]
18. Constitutive upregulation of chaperone-mediated autophagy in Huntington's disease.
Koga H; Martinez-Vicente M; Arias E; Kaushik S; Sulzer D; Cuervo AM
J Neurosci; 2011 Dec; 31(50):18492-505. PubMed ID: 22171050
[TBL] [Abstract][Full Text] [Related]
19. Protein degradation in a LAMP-2-deficient B-lymphoblastoid cell line from a patient with Danon disease.
Sánchez-Lanzas R; Alvarez-Castelao B; Bermejo T; Ayuso T; Tuñón T; Castaño JG
Biochim Biophys Acta; 2016 Aug; 1862(8):1423-32. PubMed ID: 27130438
[TBL] [Abstract][Full Text] [Related]
20. Chaperone-mediated autophagy: roles in disease and aging.
Cuervo AM; Wong E
Cell Res; 2014 Jan; 24(1):92-104. PubMed ID: 24281265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
